HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Endocrine Bone Diseases

Subscribe to New Research on Endocrine Bone Diseases

Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.

Also Known As:

Bone Diseases, Endocrine; Bone Disease, Endocrine; Disease, Endocrine Bone; Diseases, Endocrine Bone; Endocrine Bone Disease

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Osteomalacia
2.	Primary Hyperparathyroidism
3.	Osteoporosis
4.	Osteitis Deformans (Paget's Disease of Bone)
5.	Neoplasm Metastasis (Metastasis)

Experts

1.	Kidney, Beverly A: 1 article (09/2007)
2.	Fernandez, Nicole J: 1 article (09/2007)
3.	Derasmo, E: 1 article (01/2002)
4.	Mazzaferro, S: 1 article (01/2002)
5.	Pepe, J: 1 article (01/2002)
6.	Pacitti, M T: 1 article (01/2002)
7.	Carnevale, V: 1 article (01/2002)
8.	De, Geronimo S: 1 article (01/2002)
9.	Scillitani, A: 1 article (01/2002)
10.	Dionisi, S: 1 article (01/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Endocrine Bone Diseases:

1.	Alkaline PhosphataseIBA 09/01/2007 - "Bone disease, endocrine disease, neoplasia, and other disorders can result in increased alkaline phosphatase activity. " 03/03/1990 - "In general, alkaline phosphatase and hydroxyproline levels had a higher sensitivity than those of osteocalcin in structural bone disease (Paget's disease, blastic or lytic metastases), whereas the converse was true for endocrine bone disease (the remaining conditions except osteomalacia, which is mixed, both structural and endocrine; in this syndrome, the three substances showed the same sensitivity."
2.	OsteocalcinIBA 03/03/1990 - "In general, alkaline phosphatase and hydroxyproline levels had a higher sensitivity than those of osteocalcin in structural bone disease (Paget's disease, blastic or lytic metastases), whereas the converse was true for endocrine bone disease (the remaining conditions except osteomalacia, which is mixed, both structural and endocrine; in this syndrome, the three substances showed the same sensitivity."
3.	Hydroxyproline (4 Hydroxyproline)IBA 03/03/1990 - "In general, alkaline phosphatase and hydroxyproline levels had a higher sensitivity than those of osteocalcin in structural bone disease (Paget's disease, blastic or lytic metastases), whereas the converse was true for endocrine bone disease (the remaining conditions except osteomalacia, which is mixed, both structural and endocrine; in this syndrome, the three substances showed the same sensitivity."
4.	tranilast (N 5')IBA 01/01/2002 - "Serum levels of the two markers were also assessed in several groups of patients of both sexes presenting with the most common metabolic and endocrine bone diseases: established osteoporosis (n = 77), primary hyperparathyroidism (n = 44), glucocorticoid excess (n = 17), chronic renal failure (n = 39), active Paget's disease of bone (n = 5), humoral hypercalcemia of malignancy (n = 3), osteomalacia (n = 3), hyperthyroidism (n = 10), post-surgical hypoparathyroidism (n = 10), acromegaly (active disease, n = 8) and Cushing's syndrome (n = 10). "